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Local tumor progressionAbstract Objective: To evaluate the feasibility of DWI and the corresponding ADC values to
detect local tumor progression (LTP) after radiofrequency ablation for hepatocellular carcinoma.
Materials and methods: 139 MR examinations were done for 51 HCC patients post-RFA. Pre and
postgadolinium enhanced images as well as DW sequences were performed. ADC values of ablation
zones and liver parenchyma were assessed. ADC values of ablation zones and adjacent signal alter-
ations identiﬁed in DWI were analyzed.
Results: LTP was detected in 12 patients (23.5%) and 16 lesions (21.9%). The mean ADC value of
ablated zones differed signiﬁcantly from that of normal liver parenchyma. No obvious changes were
detected in the ADC values of the ablated zones over time. ROIs covering the whole ablation zone
showed no signiﬁcant ADC value difference regarding the presence or absence of LTP. DWI
showed 53 hyperintense areas in the periphery of the ablated zones, and the corresponding ADC
values were signiﬁcantly lower in patients with LTP than in patients without LTP.
Conclusion: DWI is a feasible follow-up tool for postablation liver contributing in detection of
LTP. ADC based evaluation of signal alterations in the periphery of the ablation zone may be help-
ful in differentiation between LTP and post treatment tissue changes.
 2015 The Author. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hepatocellular carcinoma (HCC) is a major global health
problem with an estimated incidence ranging between
500,000 and 1,000,000 new cases annually (1).
During the past two decades, liver transplantation and par-
tial hepatectomy have been considered the main curative
582 M.A. Nasseftreatments. However, the international shortage of liver
donors, the strict patient selection criteria, and the high
cost of surgical procedure limit the practical use of liver
transplantation and unfortunately, only 10–30% of HCCs
are amenable to ‘‘curative’’ surgical resection at the time of
diagnosis (2,3).
Radiofrequency ablation (RFA) has become a widely used
treatment for HCC with some studies reporting signiﬁcant
long-term survival results (4).
For several years magnetic resonance imaging (MRI) has
been used for the evaluation of treatment response in malig-
nant liver lesions (5). However, the assessment of tumor
response remains difﬁcult. Residual contrast enhancement
may also be difﬁcult to appreciate (6). Furthermore, focal liver
lesions treated by RF ablation often contain a hypersignal on
T1-weighted MR sequences, corresponding to coagulation
necrosis, which makes any residual tumoral contrast enhance-
ment difﬁcult to be differentiated (7).
Diffusion-weighted MRI (DW-MRI), primarily performed
in neuroradiology for acute stroke, has then been introduced
into abdominal imaging representing a supplementary tool
for detecting and characterizing hepatic lesions (8).
Based on the calculation of apparent diffusion coefﬁcients
(ADC), DWI allows for characterization of biological tissue
on the basis of its water diffusion properties that are deter-
mined by the microstructure organization, cell density, and
viability of the tissue (9).
Studies investigating time-related image characteristics and
histopathological ﬁndings after hepatic RF ablation identiﬁed
typical changes in the microstructure of the coagulation zone
(10).
It is a challenge to improve follow-up imaging identifying
any residual tumor or tumor regrowth, called local tumor pro-
gression (LTP) as early as possible.
The aim of the current study was to evaluate time-related
diffusion alterations after hepatic RF ablation giving an added
value in diagnosis of viable HCC tumor for early detection of
LTP.2. Materials and method
This prospective study was conducted during the period
between February 2012 and November 2014 at the
Radiodiagnosis Department, Ain Shams University on 51
patients (34 males and 17 females, mean age 54), suffering
from HCC, who are candidates for radiofrequency ablation
and already underwent the procedure. Written and verbal
consents were obtained from all patients as well as an agree-
ment of the local ethics committee.
Exclusion criteria:
Patients with MRI incompatible devices such as cardiac
pacemaker, metallic valves, hearing aids or aneurismal
clips.
2.1. RF ablation system
Radiofrequency ablations were performed under ultrasound
(US) guidance. Patients were treated under general sedation.
A Covidien/Valley Lab RF ablation system (RF AblationSystem, E series, Covidien/Valley Lab, Boulder, CO, USA)
was used to deliver RF ablation energy to the targeted lesions.
Single, clustered, or multiple cooled electrodes (Cool-Tip
Ablation electrodes) were used according to the size and shape
of the tumor to be treated. Radiofrequency energy was applied
from 12 to 15 min, according to the manufacturer’s recommen-
dations, with automated control of the impedance.
Radiofrequency ablations were considered successful when
the temperature in the lesion was 70 C or higher. Patients
were discharged the day following the procedure.
2.2. MR study
Follow-up MR is systematically scheduled one month after the
RF intervention then every 3 months for 1 year, and from
thereon every 6 months. Additional follow-up examinations
are performed depending on the individual course of the
disease.
2.2.1. Patients preparation
No preparation was done. The patients were sent for follow-up
at the MRI unit, Radiodiagnosis Department in Ain Shams
University Hospital.
2.2.2. MR protocol
Magnetic resonance imaging examinations were performed on
a Philips Intera Achieva 1.5 T super conducting MR unit
(Philips Medical Systems, the Netherlands), with a 16-
channel body coil.
Breath-hold T1-weighted image and single shot fast spin
echo (SSFSE) T2 weighted images were obtained. Diffusion
weighted images were obtained before contrast administration
with b values of 0, 500, and 1000 s/mm2. Breath-hold, dynamic
3D T1 weighted sequence was performed after DWIs (bolus
injection of 0.1 mmol/kg gadopentetate dimeglumine 2 ml/s)
followed by ﬂush saline. All DWIs were obtained in transverse
plane using single-shot echo-planar spin echo sequences.
Imaging parameters for DWIs were: TR: 1200 ms; TE:
90 ms; FOV: 38 cm · 38 cm (change according to body size);
number of excitation: 1; matrix size: 192 · 192; section thick-
ness: 4 mm; intersection gap: none. DW sequences required a
total of 2 min to scan on MR.
2.3. MR analysis
2.3.1. Image analysis and ADC measurements
All MR images were reviewed on a commercial workstation
(HPZR 24 W Easy Vision; Philips Medical Systems worksta-
tion). The reviewers were blinded to the course of ablation,
MR reports, clinical history and follow-up results.
DW images of each patient were reviewed before the stan-
dard MR examination including T1-, T2-weighted, and the
dynamic series of gadolinium-enhanced images. Ablation size
was assessed in T1, DWI (b= 0) and contrast-enhanced T1
by the measurement of the largest long and short axes of the
coagulated area.
ADC of each ablation zone was measured by drawing a free
hand region of interest (ROI) around the outlines of each abla-
tion zone on the DWI (b= 0 s/mm2) images. ROIs were then
automatically transferred to the ADC map and the corre-
sponding ADC value of the ablation zone was registered.
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(at least 10 mm in diameter) were drawn within normal liver
parenchyma (subsegment 6 if possible) by carefully avoiding
large vascular and biliary structures larger than 3 mm. The
examinations were grouped in control intervals (according to
the interval between RF procedure and follow-up MR exami-
nation) in order to identify changes of the ablation’s ADC
values over time. ADC values of the ablation zones were
analyzed statistically regarding presence of LTP.
2.3.2. Signal alteration in the periphery of the ablation zone
The periphery of the ablation zone was analyzed in the DW
images with regard to signal abnormalities. If a focal area of
hyperintensity was detected adjacent to the ablation zone in
the b= 0 image, which did not decrease in images with higher
b-value, it was considered suspicious for LTP and the corre-
sponding ADC value of the area was recorded by drawing a
ROI that completely covered the hyperintense area which
was copied and pasted from the DW image to the ADC map.
The ADC ratio (ADC hyperintense area/ADC liver) was
calculated in order to minimize effects related to individually
modiﬁed diffusion properties caused by underlying hepatic tis-
sue changes, such as steatosis or ﬁbrosis. The calculated ADC
ratios were analyzed regarding presence of LTP.
2.3.3. Standard of reference
According to the current practice reported in the literature, the
standard of reference for successful therapy was represented by
all available follow-up imaging results, clinical history, and
pathologic ﬁndings. Treatment result was grouped in ‘‘com-
plete ablation’’ showing regular, nonenhancing rim of the abla-
tion zone that is stationary or decreasing in size in the long-
term follow-up (at least 12 months) and ‘‘LTP presenting
new enhancement areas, increase in size and development of
T1-weighted hypointense and T2-weighted hyperintense areas.
The general observation period including imaging as well as
clinical follow-up of the patients ranged between 13 and
25 months.
2.3.4. Statistical analysis
The analysis was done using the JMP software version 8.0. The
Wilcoxon test was used to compare the ADC ratios.
Signiﬁcance level was set to 0.05.
3. Results
One hundred and thirty-nine consecutive follow-up MR exam-
inations of 73 ablation zones in 51 patients were investigated.
Table 1 shows a list of patients, ablated zones and their follow-
up results.Table 1 List of patients, ablated zones and their follow-up
results.
Examinations Ablated zones Patients
139 73 51
No LTP LTP NO LTP LTP
57
(78.1%)
16
(21.9%)
39
(76.5%)
12
(23.5%)Absence of LTP at MR follow-up imaging (Fig. 1) was
achieved in 39 of all 51 patients (76.5%). As regards the num-
ber of treated lesions per patient, the LTP occurred in 16
lesions (21.9%). Mean size of all ablations assessed by mea-
surement of the largest long and short axis in the different
sequences was: 3.8 cm · 2.5 cm in T1, 3.6 cm · 2.5 cm in post-
contrast T1, and 3.3 cm · 2.3 cm in the b = 0 s/mm2 images.
3.1. ADC values
The mean ADC value of normal liver parenchyma was
1.11 ± 0. 26 · 103 mm2/s while that for the ablation zones
was 1.26 ± 0.33 · 103 mm2/s. Signiﬁcant difference in ADC
between liver and ablation zones (P= 0.0004) was found after
analyzing all the ADC values obtained during the whole study.
There were no obvious changes in the ADC values of the
ablated zones over time. ROIs covering the whole ablation
zone showed no signiﬁcant difference regarding the presence
of LTP (1. 25 ± 0.31 · 103 mm2/s in cases with LTP versus
1.29 ± 0.35 · 103 mm2/s in cases without LTP).
Fig. 2 shows mean ADC values of the ablation zones and
liver at different time intervals after RF procedure.
3.2. Periphery of the ablation zone signal alteration
In the 139 examinations, 53 focal hyperintense areas at the
periphery of the ablation zone were detected in the DW
images. Most of the foci were detected within the ﬁrst control
examinations (<180 days after RF procedure). Fig. 3 shows
interval detection of hyperintensities at the periphery of the
ablated zones.
In 16 of the newly detected hyperintensities, LTP was con-
ﬁrmed at follow-up (Fig. 4).
In the other 37 lesions with hyperintensities, the majority of
the foci disappeared over time: 26 of 37 (70.3%) were no
longer detectable in the subsequent follow-up MR examina-
tion, whereas 11 of 37 (29.7%) persisted in subsequent MR
examinations (mean time of persistence: 115 days ± 46 days)
(Figs. 5 and 6).
The corresponding ADC values of the hyperintense areas
were signiﬁcantly lower in cases with LTP conﬁrmed at
follow-up than in cases without LTP (1.06 ± 0.21 ·
103 mm2/s versus 1.36 ± 0.44 · 103 mm2/s P= 0.013).
The mean ADC ratio (ADC hyperintense area/ADC liver)
in the cases with complete ablation was 1.23 ± 0.39 versus
0.96 ± 0.23 in cases with LTP at follow-up.
Fig. 7 shows the ADC ratios of both groups.
The difference in ADC ratios of the two groups (with and
without LTP) proved to be signiﬁcant (P = 0.003).
4. Discussion
Treatment efﬁcacy and ablative margin after RFA are conven-
tionally evaluated by enhanced CT or MRI with dynamic
study. Enhanced CT and MRI performed after RFA have
some limitations. Benign periablational enhancement, which
can be seen immediately and can last for up to 6 months after
ablation, is difﬁcult to differentiate from residual unablated
tumor. Next, enhanced CT or MRI is not able to evaluate
both the ablative margin and index tumors on identical images
(11–13).
Fig. 1 Well ablated right hepatic lobe HCC. Images taken one month after RFA show right hepatic lobe segment VIII large well deﬁned
wedge shaped area eliciting high T1 (A) and low T2 (B) signal with no evidence of pathological enhancement through the dynamic arterial
(C), porto-venous (D), delayed (E) images, no restriction in the DWI (F) with the ADC (G) maps showing high value (1.28 · 103 mm2/s).
No LTP was detected in the follow-up studies.
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Fig. 2 Mean ADC values of the ablation zones and liver at
different time intervals after RF procedure.
Added value of diffusion weighted MRI 585The diagnostic management of the post-RF ablation liver
remains a challenging issue that is related to difﬁculties in
accurately differentiating residual or recurrent vital tumor
from nontumoral tissue changes following thermal therapy.
DWI is increasingly applied in the evaluation of treatment
effectiveness in the oncologic patient (14). DWI technique
can provide qualitative and quantitative information about
molecular tissue characteristics and may offer additional diag-
nostic information in the follow-up MR imaging after hepatic
RF ablation (15).
In the present study the overall LTP rate of 21.9% (Table 1)
is in accordance with values published in the literature (16).
Several studies have been performed focusing on time-related
histopathological changes after RF ablation, especially with
regard to the differentiation between post-treatment tissue
and residual or recurrent tumor tissue (17).
It could be shown in the present study, that the ablation
zones can be differentiated from surrounding liver parenchyma
visually in the DW images and by means of ADC maps in all
patients. However analysis of ablation zones examined at dif-
ferent time points after the RF procedure revealed no signiﬁ-
cant changes in ADC values over time which agrees with Lu
et al. (18) who in their study assessed the liver tumor response0 
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Fig. 3 Interval detection of hyperintensities at the periphery of
the ablated zones.in the ablation zone after RF ablation found that the ADC
value does not show signiﬁcant changes over time.
The heterogeneous appearance of the ablation zone reﬂect-
ing the different posttreatment tissue changes that can be
found after RF ablation is mainly due to coagulative necrosis,
hemorrhagic products, and dehydration (19).
The abovementioned changes are present at varying degree
depending on the individual conditions in each patient. This
may explain the ﬁnding that ADC values obtained from
ROIs covering the whole ablation zone did not differ signiﬁ-
cantly regarding occurrence of LTP at follow-up; thus, it is
not suitable to use the ‘‘ADC value of the entire ablation
zone’’ as an indicator for LTP. If there are any measurable dif-
ferences in the ADC values regarding LTP, those differences
are masked by the heterogeneous appearance of the entire
ablation zone produced by the varying posttreatment tissue
changes.
Several studies (20,21) found that the LTP rate tends to be
lower in HCC patients with an adequate ablation margin, it
has to be considered that LTP mainly occurs in the periphery
of the ablation zone which is often not completely included in
the ROI, being drawn along the macroscopically visible con-
tours of the ablation zone, thus it is very important to analyze
the periphery of the ablation zone separately.
Abdominal DW images are less common than standard T1-
and T2-weighted imaging and therefore may be difﬁcult to
interpret. Viable tumor regions appear hyperintense (bright)
on DW images, whereas necrotic regions appear hypointense
(dark) (9).
The present study indicates, that DWI may offer additional
diagnostic possibilities in the follow-up after RF ablation.
First, DW images could be used as a ‘‘screening sequence’’
because viable tumor regions and suspected areas in the
periphery of the ablation zone could be identiﬁed more easily,
and analyzed precisely in conjunction with the conventional
T1, T2, and dynamic contrast-enhanced images.
Benign periablational enhancement surrounding the abla-
tion zone is frequently found to show moderate to intense
peripheral rim-like enhancement on the arterial phase of
contrast-enhanced MRI which may persist on the delayed
phase. This rim has low-signal intensity on T1-, and high-
signal intensity on T2-weighted images. Histologic analysis
of the perilesional rim has revealed that it is initially reactive
hyperemia and subsequently ﬁbrosis and a giant cell reaction
(22).
The present study indicates that ADC maps could be help-
ful in the analysis of unclear hyperintense areas adjacent to the
ablation zone differentiating between tumoral tissue and post-
treatment changes. It could be demonstrated in this study, that
unclear signal alterations in the periphery of the ablation zone
exhibited markedly lower ADC values in patients with conﬁr-
mation of LTP at follow-up. This is due to the fact that ther-
apeutically induced nontumoral tissue changes (e.g., edema,
inﬂammation, ﬁbrosis, and necrosis) usually show low cellular-
ity and therefore present with less signal in DWI (and high
ADC, respectively), and can thereby be distinguished from
tumoral tissue that presents with high signal in DWI (and
low ADC value, respectively) (15). This is in accordance with
Schraml et al. (23) and Kim et al. (24) who in their studies
regarding the DW-MRI and ADC values for follow-up after
RF ablation, found that ADC maps could be helpful for ana-
lyzing unclear hyperintense areas adjacent to the ablation zone
Fig. 4 Images obtained one month after RF ablation for HCC at subsegment 7, and the lesion appears hyperintense on T1 (A),
hypointense on T2 (B), showing marginal enhancement persisting in the porto-venous phase (C). Its margin presents bright signal on DWI
(D) and dark in the corresponding ADC (E) images, and the ADC value of the entire area revealed a relatively high value
(1.25 · 103 mm2/s); however studying the peripheral margin alone revealed signiﬁcant low ADC values (1.07 · 103 mm2/s). In long term
follow-up it showed evidence of LTP. Ill deﬁned marginal enhancement was noted at the anterior aspect of subsegment 8 appearing
relatively bright on DWI, however not appreciated in the corresponding ADC, disappearing in long term follow-up which could represent
transient hepatic intensity differences.
586 M.A. Nassefwhere differentiation between tumor tissue and post-treatment
changes is unambiguous. It has been demonstrated that
unclear signal alterations in the periphery of the ablation zoneexhibited markedly lower ADC values in patients with local
tumor progression on follow-up DW-MRI and in the ADC
map.
Fig. 5 Images obtained one month after RF ablation for HCC at subsegment 5, the lesion appears hypointense on T1 (A) and T2 (B),
and the margin appears hyperintense on T1. After gadolinium administration persistent marginal enhancement is noted in arterial phase
(C) slightly decreasing in the porto-venous phase (D). DWI (E) presents marginal bright signal, however being not dark in the
corresponding ADC (F) with high value (1.27 · 103 mm2/s) denoting post therapy changes. In long term follow-up the marginal DWI
bright signal disappeared showing no evidence of LTP.
Added value of diffusion weighted MRI 587In the present study, a relatively high number of ‘‘false pos-
itive cases’’ were observed, with hyperintense areas being
detected in the high b-value DW images, which did not corre-
spond to LTP. This was also detected by Park et al. (25) who
found that tumor necrosis intermingled with ﬁbroticcomponent and inﬂammatory granulation tissues may show
diffusion restriction, and can sometimes mimic viable tumor.
These encountered DW signal alterations could be ascribed
to transient postinterventional perfusion inhomogeneities in
the surrounding of the ablation zone and to postinterventional
Fig. 6 Images obtained four months after RF ablation for HCC at subsegment 7, the lesion appears hyperintense on T1 (A) and
isointense on T2 (B), and the margin appears hyperintense on T1. After gadolinium administration no appreciable enhancement seen in
the arterial (C) nor porto-venous (D). DWI (D) presents marginal bright signal, however being also bright in the corresponding ADC (E)
showing high value (1.25 · 103 mm2/s). In long term follow-up the DWI marginal bright signal disappeared, showing no evidence of
LTP.
588 M.A. Nassefbile duct irregularities with subsequent focal cholestase.
However, such processes are expected to be associated with
high ADC values, so that the corresponding ADC maps
should facilitate the differentiation from LTP.This prospective study had two limitations. The limited
spatial resolution of DWI, and the decreased signiﬁcance of
a ROI analysis. Thus, the use of ADC values derived from
ROIs that include the entire ablation area may not adequately
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Fig. 7 The ADC ratios (ADC hyperintense area/ADC liver) of
both groups.
Added value of diffusion weighted MRI 589reﬂect the heterogeneity within an ablation zone. The ongoing
technical development will lead to optimization of sequence
technique giving a more detailed spatial analysis, especially
of the marginal zone that is at risk for LTP. Moreover, detec-
tion of small LTP may be improved.
Second, histopathological results were not available for
most patients so that RFA success was mostly evaluated on
follow-up imaging and clinical parameters (e.g., tumor mark-
ers). Long observation period was chosen to overcome this,
and to guarantee accurate diagnosis.
5. Conclusion
Unlike treatment of other oncologic tumors, locoregional ther-
apies are mainstay treatments of HCC with RFA becoming
widely used. Treatment response assessment using imaging is
a key factor in the management of patients with HCC.
Conventional MRI is inconclusive in detecting viable tumor
in postablation patients.
In conclusion, the present study demonstrates that DWI is
a feasible follow-up tool for postablation liver providing more
information regarding the viability of treated HCCs and con-
tributing in detection of LTP. Although no signiﬁcant changes
in ADC obtained from the entire ablation zones were detected
over time, yet ADC-based evaluation of signal alterations in
the periphery of the ablation zone may be helpful in differen-
tiation between LTP and post treatment tissue changes.
Conﬂict of interest
The authors declare that there are no conﬂict of interests.
References
(1) Lau WY, Lai EC. Hepatocellular carcinoma: current manage-
ment and recent advances. Hepatobiliary Pancreat Dis Int
2008;7:237–57.
(2) Sauer P, Kraus TW, Schemmer P, Mehrabi A, Atremmel W,
Buechler MW, et al. Liver transplantation for hepatocellular
carcinoma: is there evidence for expanding the selection criteria?
Transplantation 2005;80:105–8.(3) Lau WY. The history of liver surgery. J R Coll Surg Edinb
1997;42:303–9.
(4) Garrean S, Hering J, Saied A, Helton WS, Espat NJ.
Radiofrequency ablation of primary and metastatic liver tumors:
a critical review of the literature. Am J Surg 2008;195(4):508–20.
(5) Stubbs M, Grifﬁths JR. Monitoring cancer by magnetic reso-
nance. Br J Cancer 1999;80(1):86–94.
(6) Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R,
Burroughs AK, et al. Clinical management of hepatocellular
carcinoma. Conclusions of the Barcelona-2000 EASL conference.
European Association for the Study of the Liver. J Hepatol
2001;35:421–30.
(7) Lee CH, Braga L, de Campos RO, Semelka RC. Hepatic tumor
response evaluation by MRI. NMR Biomed 2011;24(6):721–33.
(8) Bruegel M, Holzapfel K, Gaa J, Woertler K, Waldt S, Kiefer B,
et al. Characterization of focal liver lesions by ADC measure-
ments using a respiratory triggered diffusion-weighted singleshot
echo-planar MR imaging technique. Eur Radiol 2008;18:477–85.
(9) Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maier SE,
Cohen S, et al. High-b-value diffusion weighted MR imaging for
pretreatment prediction and early monitoring of tumor response
to therapy in mice. Radiology 2004;232:685–92.
(10) Sofocleous CT, Klein KM, Hubbi B, Brown KT, Weiss SH,
Kammarkat G, et al. Histopathologic evaluation of tissue
extracted on the radiofrequency probe after ablation of liver
tumors: preliminary ﬁndings. AJR Am J Roentgenol
2004;183:209–13.
(11) Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto
Y, et al. Radiofrequency ablation of the liver: determination of
ablative margin at MR imaging with impaired clearance of
ferucarbotran––feasibility study. Radiology 2009;251(2):557–65.
(12) Tokunaga S, Koda M, Matono T, Sugihara T, Nagahara T, Ueki
M, et al. Assessment of ablative margin by MRI with ferucar-
botran in radiofrequency ablation for liver cancer: comparison
with enhanced CT. Br J Radiol 2012;84(1014):745–52.
(13) Okubo H, Kokubu S, Komiyama M, Yamagata H, Uchiyama A,
Miyazaki A, et al. Radiofrequency ablation of hepatocellular
carcinoma: the feasibility of magnetic resonance imaging with
gadolinium ethoxybenzyl diethylene triamine pentaacetic acid for
evaluating the ablative margin. Hepatol Res 2010;40(10):1034–41.
(14) Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO,
et al. Diffusion-weighted MRI in the body: applications and
challenges in oncology. AJR Am J Roentgenol 2007;188:1622–35.
(15) Vandecaveye V, De Keyzer F, Nuyts S, Deraedt K, Dirix P,
Hamaekers P, et al. Detection of head and neck squamous cell
carcinoma with diffusion weighted MRI after (chemo)radiother-
apy: correlation between radiologic and histopathologic ﬁndings.
Int J Radiat Oncol Biol Phys 2007;67:960–71.
(16) Zytoon AA, Ishii H, Murakami K, El-kholy MR, Furuse J, El-
dorry A, et al. Recurrence-free survival after radiofrequency
ablation of hepatocellular carcinoma. A registry reporting the
impact of risk factors on outcome. Jpn J Clin Oncol
2007;37(9):658–72.
(17) Limanond P, Zimmerman P, Raman SS, Kadell BM, Lu DS.
Interpretation of CT and MRI after radiofrequency ablation of
hepatic malignancies. AJR Am J Roentgenol 2003;181:1635–40.
(18) Lu T-L, Becce F, Bize P, Denys A, Meuli R, Schmidt S.
Assessment of liver tumor response by high-ﬁeld (3 T) MRI after
radiofrequency ablation: short- and mid-term evolution of
diffusion parameters within the ablation zone. Eur J Radiol
2012;9:944–50.
(19) Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V,
et al. Hepatic tumors treated with percutaneous radio-frequency
ablation: CT and MR imaging follow-up. Radiology
2002;223:255–62.
(20) Minami Y, Nishida N, Kudo M. Therapeutic response assessment
of RFA for HCC: contrast-enhanced US, CT and MRI. World J
Gastroenterol 2014;20(15):4160–6.
590 M.A. Nassef(21) Koda M, Tokunaga S, Miyoshi K, Kishina M, Fujise Y, Kato J,
et al. Assessment of ablative margin by unenhanced magnetic
resonance imaging after radiofrequency ablation for hepatocellu-
lar carcinoma. Eur J Radiol 2011;81(10):2730–6.
(22) Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd 3rd
GD, Dupuy DE, et al. Image-guided tumor ablation: standard-
ization of terminology and reporting criteria. J Vasc Interv Radiol
2009;20(7):S377–90.
(23) Schraml C, Schwenzer NF, Clasen S, Rempp HJ, Martirosian P,
Claussen CD, et al. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency
ablation––initial results. J Magn Reson Imaging 2009;29:1308–16.
(24) Kim KW, Lee JM, Choi BI. Assessment of the treatment response
of HCC. Abdom Imaging 2011;36:300–14.
(25) Park HJ, Kim SH, Jang KM, Lim S, Kang TW, Park HC, et al.
Added value of diffusion-weighted MRI for evaluating viable
tumor of hepatocellular carcinomas treated with radiotherapy in
patients with chronic liver disease. AJR 2014;202:92–101.
